Literature DB >> 20519638

The invariant NKT cell subset in anti-viral defenses: a dark horse in anti-influenza immunity?

R R Kulkarni1, S M Haeryfar, S Sharif.   

Abstract

iNKT cells, a small subset of αβ TCR+ T cells, are capable of producing large amounts of cytokines upon activation through their TCR. Unlike conventional T cells that express highly diverse TCRs, iNKT cells express a glycolipid-reactive invariant TCR-α chain paired with a limited number of β chain(s). These cells recognize glycolipid antigens when presented on CD1d molecules found on APC or other cells. Although the immunoregulatory roles of iNKT cells in the context of autoimmune disease are fairly well characterized, several lines of evidence highlight the importance of this cell type in immune responses against microbial insults caused by bacterial, viral, and parasitic pathogens. Recent studies that have investigated the role of iNKT cells in immune responses against influenza virus have suggested an important role for these cells in innate defense mechanisms as well as antibody- and cell-mediated responses. This review highlights the important contributions of iNKT cells to immune responses against viral pathogens with particular emphasis on immunity to influenza infections.

Entities:  

Mesh:

Year:  2010        PMID: 20519638     DOI: 10.1189/jlb.0410191

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  12 in total

1.  Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Authors:  Christophe Paget; Stoyan Ivanov; Josette Fontaine; Joelle Renneson; Fany Blanc; Muriel Pichavant; Laure Dumoutier; Bernhard Ryffel; Jean Christophe Renauld; Philippe Gosset; Pierre Gosset; Mustapha Si-Tahar; Christelle Faveeuw; François Trottein
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

2.  A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection.

Authors:  Joelle Renneson; Rodrigo Guabiraba; Isabelle Maillet; Rafael E Marques; Stoyan Ivanov; Josette Fontaine; Christophe Paget; Valérie Quesniaux; Christelle Faveeuw; Bernhard Ryffel; Mauro M Teixeira; François Trottein
Journal:  Am J Pathol       Date:  2011-08-16       Impact factor: 4.307

Review 3.  Role of T cell immunity in recovery from influenza virus infection.

Authors:  Jie Sun; Thomas J Braciale
Journal:  Curr Opin Virol       Date:  2013-05-27       Impact factor: 7.090

4.  Natural killer T cell based Immunotherapy.

Authors:  Priyanka B Subrahmanyam; Wenji Sun; James E East; Junxin Li; Tonya J Webb
Journal:  J Vaccines Vaccin       Date:  2012-08-23

Review 5.  Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response.

Authors:  Wei Liu; Sally A Huber
Journal:  Virol J       Date:  2011-01-21       Impact factor: 4.099

6.  IL-15 participates in the respiratory innate immune response to influenza virus infection.

Authors:  Katherine C Verbist; David L Rose; Charles J Cole; Mary B Field; Kimberly D Klonowski
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

7.  Rapid control of pandemic H1N1 influenza by targeting NKT-cells.

Authors:  Bianca L Artiaga; Guan Yang; Tarun E Hutchinson; Julia C Loeb; Jürgen A Richt; John A Lednicky; Shahram Salek-Ardakani; John P Driver
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

8.  Expansion of highly activated invariant natural killer T cells with altered phenotype in acute dengue infection.

Authors:  A Kamaladasa; N Wickramasinghe; T N Adikari; L Gomes; N L A Shyamali; M Salio; V Cerundolo; G S Ogg; G Neelika Malavige
Journal:  Clin Exp Immunol       Date:  2016-08       Impact factor: 4.330

Review 9.  Invariant NKT cells: regulation and function during viral infection.

Authors:  Jennifer A Juno; Yoav Keynan; Keith R Fowke
Journal:  PLoS Pathog       Date:  2012-08-16       Impact factor: 6.823

10.  α-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant.

Authors:  Bianca L Artiaga; Guan Yang; Timothy J Hackmann; Qinfang Liu; Jürgen A Richt; Shahram Salek-Ardakani; William L Castleman; John A Lednicky; John P Driver
Journal:  Sci Rep       Date:  2016-03-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.